Baricitinib for the Lung Injury Following Spontaneous SAH

Clinical trial NCT06439615 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06439615
Sponsor: Tang-Du Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Spontaneous Subarachnoid Hemorrhage

Start date: 2024-08-01
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.